Ram Awadh Singh Kushwaha
Overview
Explore the profile of Ram Awadh Singh Kushwaha including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Verma A, Pandey A, Gupta A, Verma U, Kant S, Kushwaha R, et al.
Natl J Maxillofac Surg
. 2023 Jan;
13(3):437-442.
PMID: 36683931
Background: There is strong evidence that periodontal disease (PD) is related to various systemic diseases including respiratory diseases. Dental plaque is the primal cause of PD, and it can also...
2.
Mohit , Tomar M, Araniti F, Pateriya A, Kushwaha R, Singh B, et al.
Front Mol Biosci
. 2022 Dec;
9:1026848.
PMID: 36504723
Obstructive sleep apnea (OSA) is considered a major sleep-related breathing problem with an increasing prevalence rate. Retrospective studies have revealed the risk of various comorbidities associated with increased severity of...
3.
Tyagi R, Kant S, Verma S, Kushwaha R, Kumar S, Garg R, et al.
Monaldi Arch Chest Dis
. 2021 Dec;
92(3).
PMID: 34873902
Interstitial lung diseases (ILDs) are an intriguing group of pulmonary disorders, which still require the study of epidemiological, genetic, pathophysiological, clinical, and radiological parameters. Pulmonary hypertension (PH) is an underreported...
4.
Singh A, Prasad R, Kushwaha R, Srivastava R, Giridhar B, Balasubramanian V, et al.
Lung India
. 2019 Aug;
36(5):384-392.
PMID: 31464209
Background: Multidrug-resistant tuberculosis (MDR-TB) is a global health problem with notoriously difficult and challenging treatment. This study determined treatment outcome in patients of MDR-TB with modified DOTS-Plus strategy. Methods: Ninety-eight...
5.
Tripathi P, Kant S, Yadav R, Kushwaha R, Prakash V, Rizvi S, et al.
Oman Med J
. 2017 Dec;
32(6):477-485.
PMID: 29218124
Objectives: Chronic obstructive pulmonary disease (COPD) is one of the leading causes of morbidity and mortality around the world. Preliminary studies have evaluated the association between innate immunity including Toll-like...
6.
Prasad R, Singh A, Srivastava R, Hosmane G, Kushwaha R, Jain A
Indian J Tuberc
. 2016 Jul;
63(2):106-14.
PMID: 27451820
Background: Multidrug-resistant tuberculosis (MDR-TB) is considered to be a worldwide problem with notoriously difficult and challenging treatment. Adverse events associated with second-line drugs (SLDs) can have severe impact on efficient...
7.
Singh A, Maurya A, Umrao J, Kant S, Kushwaha R, Nag V, et al.
J Lab Physicians
. 2014 Apr;
5(2):83-9.
PMID: 24701099
Background: Mycobacterium tuberculosis complex (MTBC) and non-tuberculous mycobacteria (NTM) may or may not have same clinical presentations, but the treatment regimens are always different. Laboratory differentiation between MTBC and NTM...
8.
Maurya A, Umrao J, Singh A, Kant S, Kushwaha R, Dhole T
Indian J Pathol Microbiol
. 2013 Sep;
56(2):139-43.
PMID: 24056651
Background: The problem of multi-drug resistance tuberculosis (MDR-TB) is growing in several hotspots throughout the world. Rapid and accurate diagnosis of MDR-TB is crucial to facilitate early treatment and to...
9.
Maurya A, Kant S, Nag V, Kushwaha R, Kumar M, Dhole T
Tuberk Toraks
. 2011 Nov;
59(3):213-20.
PMID: 22087516
In developing countries the diagnosis of extrapulmonary tuberculosis (EPTB) is a major burning challenge. EPTB encounters many problems like pauci-bacillary nature, inadequate specimen volume. All the limitations reflect in the...